Open original FDA record ↗Recall record
- FDA identifier
- Z-2226-2023
- Company in FDA record
- Medtronic Neuromodulation
- FDA classification date
- Jul 21, 2023
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
When an update to the A710 Clinician Programmer software application for the Intellis Neurostimulation System was released, the corresponding version of the A901 Communication Manager software application was not available for download.
Source facts
- Action
- Only one of the two consignees received the notification since one of the consignees independently updated their tablet. On 6/22/2023, the notification dated June 2023 was issued to the consignee via visit by the sales representative. The notification described the issue and provided required actions which included: (1) Update the A901 Comm Manager application to version 1.0.1239 on the clinician programmer (tablet), serial #NPL3011706, using the instructions listed in Appendix A, Updating Clinician Programmer Software; (2) Complete the Customer Confirmation Form enclosed with the letter acknowledging that the consignee has received this information; and (3) Share this notice with all those who need to be aware of the issue within the organization and maintain a copy of it in the records.
- Initiated
- 2023-06-21
- Root cause
- Under Investigation by firm
- Distribution
- International distribution to the countries of Israel and Serbia.
- Recall number
- Z-2226-2023
- Recall status
- Open, Classified
- CDRH record ID
- 201304
- FDA classified
- 2023-07-21
- Recall event number
- 92530